Canopus BioPharma Incorporated (CBIA) Research

Canopus BioPharma Incorporated operates as a pharmaceutical research firm, delivering a range of therapeutic products and diagnostic assay methods to individuals afflicted by infectious diseases, cancer, and addiction. The company's diverse product portfolio features antiviral medications, radiation protective agents, oncology treatments, advanced bio-barcode assays, specialized camelidae blood products, and nutritional supplements. Established in 1996 as Canopus Corporation, the enterprise adopted its current name in 2007. Canopus BioPharma's main offices are situated in Santa Monica, California.

Market snapshot

Symbol
CBIA
Price
$0.00
Day change
0.00%
Market cap
$455.1K
P/E ratio
-0.01x
52-week range
0.00001-0.0001
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • American Graphite Technologies, Inc. (AGIN)
  • Apogee 21 Holdings, Inc. (APHD)
  • Church & Crawford, Inc. (CCWF)
  • China Food and Beverage Company (CHIF)
  • Fuss Brands Corp. (FBDS)
  • International Star, Inc. (ILST)
  • Newron Sport (NSPT)
  • Puget Technologies, Inc. (PUGE)

Open Canopus BioPharma Incorporated (CBIA) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.